Message from the Chair
The Department of Pathology is a founding department of the Stanford School of Medicine and one of the leading departments in the United States. Our preeminent faculty spans...
The Dorfman Kempson Fund
Empowering the Next Generation of Pathology Leaders
Help us empower the next generation of scientists to fully leverage all that this new era of discovery has to offer.
As these young scientists go out into the world, the intellectual independence and entrepreneurial fire they gained at Stanford will go with them, and the impact of their achievements will resonate around the globe.
In the final installment of The Pandemic Puzzle: Lessons from COVID-19, leaders in government, academia, health care and business said biomedical and digital health advances of the last few years will help combat future health crises.
Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.
Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.
A comprehensive study of immune responses to SARS-CoV-2 associates mild disease with comparatively high levels of antibodies that target the viral spike protein. But all antibodies wane within months.
Stanford pathologist in the news: Stanford leaders and health experts detail university’s COVID-19 surveillance testing program…